Sun Pharmaceutical Industries Reflects Mixed Trends Amid Broader Market Movements

Sun Pharmaceutical Industries, a prominent player in the Pharmaceuticals & Biotechnology sector, has shown notable activity today, trading at Rs 1684.75. The stock's performance aligns with the sector, reflecting a slight decline of 0.72% for the day, compared to a 0.91% drop in the Sensex. Over the past week, Sun Pharma has decreased by 0.56%, while the Sensex fell by 1.79%.
In terms of moving averages, the stock is currently above its 5-day moving average but below the 20-day, 50-day, 100-day, and 200-day moving averages, indicating mixed short-term trends. With a market capitalization of Rs 3,99,801.19 crore, Sun Pharma maintains a P/E ratio of 35.22, slightly above the industry average of 34.50.

Looking at its performance over various time frames, Sun Pharmaceutical Industries has delivered a 14.12% return over the past year, significantly outperforming the Sensex's 9.12%. However, year-to-date, the stock has seen a decline of 11.58%, contrasting with the Sensex's positive return of 3.29%. Over the long term, the stock has shown impressive growth, with a 5-year performance of 252.13% compared to the Sensex's 138.60%.